"We remain optimistic as the demand for high-quality steel products has not abated." So said Steel Dynamics' (NASDAQ: STLD ) CEO Mark Millett in making yesterday's earnings announcement. But the facts beg to differ.
The $1.8 billion in sales that Steel Dynamics recorded in fiscal Q2 2013 were down about 5% from last year's Q2 sales of $1.9 billion. And with the average selling price for the company's steel dropping more than 8% per ton in comparison to last year's Q2, to $781, this hurt profits even worse. For comparison, rival mini-mill operator Nucor (NYSE: NUE ) reported�this morning that its average selling prices for steel were only down 7%. With prices and sales both down on a diluted earnings-per-share basis, Steel Dynamics reported $0.13 profit -- down 38% from last year.
So what's going on with Steel Dynamics? Basically, it's exactly what I warned you about last month, after reviewing the disturbing news of weak demand for steel in China, revealed by Schnitzer Steel (NASDAQ: SCHN ) in its earnings report. Steel Dynamics is hitting headwinds all around the globe:
Top Railroad Stocks To Invest In Right Now: IsoRay Inc (ISR)
IsoRay, Inc. (IsoRay), incorporated on June 15, 2004, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association (FDA) for treatment for all solid tumor applications using Cesium-131. Such applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer, and pancreatic cancer. The seed may be used in surface, interstitial and intracavity applications for tumors with known radio sensitivity. The Company has an existing distribution agreement with UralDial LLC (UralDial) that allows UralDial to distribute Proxcelan Cs-131 brachytherapy seeds in Russia. The Company, through UralDial, has regulatory approval to sell Cs-131 seeds in Russia.
IsoRay markets the Proxcelan Cesium-131 brachytherapy seed for the treatment of prostate cancer; lung cancer; ocular melanoma; head and neck cancers; colorectal cancer, brain cancer; and gynecological cancer. The Company focuses to market Cesium-131 for the treatment of other malignant disease, such as breast cancer, in the near future through the use of existing technologies that have received FDA-clearance. Cesium-131 is a radioactive isotope that can be produced by the neutron bombardment of Barium-130 (Ba-130). When placed into a nuclear reactor and exposed to a flux of neutrons, Ba-130 becomes Ba-131, the radioactive material that is the parent isotope of Cesium-131. The radioactive isotope Cesium-131 is normally produced by placing a quantity of stable non-radioactive barium (ideally barium enriched in isotope Ba-130) into the neutron flux of a nuclear reactor. The irradiation process converts a small fraction of this material into a radioactive form of barium (Ba-131). The Ba-131 decays by electron capture to the ! radioactive isotope of interest (Cesium-131).
As of June 30, 2011, IsoRay had agreements with several independent radiopharmacies to assay, preload, and sterilize loose seeds. During the fiscal year ended June 30, 2011, the Company loaded approximately 90% of Mick cartridges in the Company's own facility, which accounted for approximately 61% of seeds sold. Approximately 33% of seeds sold are strand configurations, including strands preloaded in needles and the remaining 6% of seeds are sold as loose seeds.
Advisors' Opinion:- [By James E. Brumley]
Ugh. It's fun to be right about a stock, but it's exhausting to be too right, too fast. Case in Point? IsoRay, Inc. (NYSE: ISR). Yours truly posted some bullish comments on ISR just a couple of days ago, explaining how that day's move above a key ceiling meant a new bull trend was underway, and more gains from that price would be far easier to muster. Well, good news for those who heeded the advice - IsoRay shares are up 44% today.
Top 5 Quality Companies To Buy For 2014: Thor Industries Inc.(THO)
Thor Industries, Inc., together with its subsidiaries, manufactures and sells a range of recreation vehicles and small and mid-size buses, as well as related parts and accessories in the United States and Canada. The company offers a range of travel trailers and motorhomes under the trade name of Airstream, which include Airstream Safari, International, Flying Cloud, and Bambi travel trailers, as well as Interstate Class B motorhomes. It also manufactures and sells conventional travel trailers and fifth wheels under the trade names of Dutchmen, Four Winds, Aero, Grand Junction, Colorado, Cruiser, Seville, Zinger, and Sunset Trail; travel trailers and fifth wheels under trade names of Montana, Springdale, Hornet, Sprinter, Outback, Laredo, Everest, Mountaineer, Challenger, Cougar, Komfort, and Trailblazer; and gasoline and diesel Class C, Class A, and Class B motorhomes under the trade names of Four Winds, Hurricane, Windsport, Mandalay, Dutchmen, Chateau, Serrano, Ventura, and Fun Mover. In addition, it manufactures and sells gasoline and diesel Class A motor homes under the trade names of Daybreak, Challenger, Astoria, Tuscany, Outlaw, and Avanti; travel trailers, fifth wheels, truck campers, and park models under the trade name of General Coach; and park models under the trade names of Tranquility, Westchester, and Breckenridge. Further, the company manufactures small and mid-size transit and commercial buses under the trade names of Aerolite, AeroElite, Aerotech, Escort, MST, Transmark, EZ Rider, Axess, Challenger, Defender, Crusader, American Cruiser, Classic Coach, EZ Trans, GC II, and Pacer. It markets its vehicles through independent dealers to municipalities and private purchasers, such as rental car companies and hotels. The company has a joint venture agreement with Cruise America, Inc. to provide short-term rentals of motorized recreation vehicles to the public. Thor Industries was founded in 1980 and is based in Jackson Center, Oh io.
Advisors' Opinion:- [By Rich Smith]
Thor Industries (NYSE: THO ) has a new CEO.
On Monday, the Elkhart, Ind.-based RV manufacturer announced it has promoted current President and Chief Operating Officer Bob Martin to the position of CEO. The appointment will become effective on August 1, when current CEO Peter B. Orthwein gives up his post (but remains executive chairman of the board of directors).
- [By Grace L. Williams]
Shares of Winnebago have gained 4.4% to $28.47 today at 3pm. Thor Industries (THO), which also makes recreational vehicles, has ticked up 0.1% to $57.56, Drew Industries (DW) has risen 0.3% to $48.74, Arctic Cat (ACAT) has advanced 1% to $59.87 and Polaris Industries (PII) has fallen 0.3% to $132.08.
- [By Lauren Pollock]
Thor Industries Inc.'s(THO) fiscal first-quarter earnings rose 33% on the strength of higher sales and wider margins. But results came in lower than expected.
- [By Rich Duprey]
Specialty vehicle maker Thor Industries� (NYSE: THO ) is selling substantially all of the assets of its ambulance division, SJC Industries, to privately held Wheeled Coach Industries, a subsidiary of Allied Specialty Vehicles, which is based in Orlando. Fla.�
Top 5 Quality Companies To Buy For 2014: DUSA Pharmaceuticals Inc.(DUSA)
DUSA Pharmaceuticals, Inc., a vertically integrated dermatology company, develops and markets Levulan photodynamic therapy (PDT) and other products for common skin conditions primarily in the United States, Canada, and Korea. Its products include Levulan Kerastick 20% Topical Solution with PDT and the BLU-U brand light source for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp. The company also markets the BLU-U without Levulan for the treatment of moderate inflammatory acne vulgaris and general dermatological conditions; and non-PDT drug products, such as ClindaReach and AVAR products. DUSA Pharmaceuticals, Inc. was founded in 1991 and is based in Wilmington, Massachusetts.
Advisors' Opinion:- [By CRWE]
DUSA Pharmaceuticals, Inc.(r) (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan(r) Photodynamic Therapy (PDT), reported that Bob Doman, President and Chief Executive Officer, will present a corporate overview at the Rodman & Renshaw 14th Annual Healthcare Conference on Monday, September 10, 2012 at 11:15 a.m. ET at The Waldorf Astoria Hotel in New York City.
Top 5 Quality Companies To Buy For 2014: Sociedad Quimica y Minera S.A.(SQM)
Chemical and Mining Company of Chile Inc. engages in the production and sale of fertilizers and specialty chemicals in Chile and internationally. The company?s specialty plant nutrients include potassium nitrate, sodium nitrate, sodium potassium nitrate, and specialty blends for crops, such as vegetables, fruits, flowers, potatoes, and cotton, as well as Ultrasol for application via fertigation; Qrop for field application; Speedfol for foliar application; Allganic for organic farming; and Nutrilake for aquaculture. It also produces iodine and iodine derivatives, which are used in a range of medical, pharmaceutical, agricultural, and industrial applications, including X-ray contrast media, polarizing films for liquid crystal displays (LCDs), antiseptics, biocides, and disinfectants; and in the synthesis of pharmaceuticals, herbicides, electronics, pigments, dye components, and heat stabilizers. In addition, the company provides lithium carbonate for use in various applicat ions comprising batteries, frits for the ceramic and enamel industries, heat-resistant glass, primary aluminum, lithium bromine for use in air conditioner equipment, and continuous casting powder for steel extrusion, pharmaceuticals, and lithium derivatives; and lithium hydroxide, which is used as a raw material in the lubricating grease industry. Further, it offers various industrial chemicals, such as sodium nitrate, potassium nitrate, and boric acid; and potassium chloride and potassium sulfate. The company was founded in 1968 and is based in Santiago, Chile.
Advisors' Opinion:- [By Dan Caplinger]
Amid the boom in Latin America lately, Chile has produced substantial amounts of economic success. But the drop in commodities markets around the world has weighed on resource-reliant industries, and Sociedad Quimica y Minera (NYSE: SQM ) is one of the companies that has suffered from that trend. On Tuesday, the company will release its latest quarterly results, and investors are nervous about whether SQM will be able to meet the growth expectations they have for the chemical company.
- [By Dan Newman]
Resilient resources
While weakness in fertilizer markets hurt Sociedad Quimica y Minera (NYSE: SQM ) this year, higher sales volume and margins in other businesses helped the company grow earnings 19% over 2012. Sociedad has a hand in many industrial resources, from iodine to lithium, and it boasts healthy double-digit profit margins. It is also expanding its production capacity to keep up with a world hungry for more fertilizer-based food and lithium-based batteries. Still, the company failed to meet recent expectations and has missed the market rally this year. If markets get spooked and head downward, investors could find peace of mind in the intrinsic value of Sociedad's physical resources, as well as its 2.6% dividend yield. - [By Jim Jubak]
His choice for the 2014 Top Stock Pick to watch out for in the coming year, is the Chemical and Mining Company of Chile (SQM).
This company's stock plunged 59% in 2013 due to weak fertilizer and phosphate prices. However, both Conrad and Jubak feel it is beginning to bounce back this year, due to a return to normalized pricing and earnings.
- [By Chris Damas]
Other players, such as K+S (KPLUY.PK), Israel Chemicals and APC, Belaruskali and Soquimich (SQM) maintained their world shares at Uralkali's expense.
No comments:
Post a Comment